##common.pageHeaderLogo.altText##

Viewpoint

Vol. 150 No. 1920 (2020)

Five reasons why data on compassionate use of remdesivir deserved publication (and are worth reading)

  • Giuseppe Lapadula
Cite this as:
Swiss Med Wkly. 2020;150:w20265
Published
04.05.2020

References

  1. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–71.https://doi.org/10.1038/s41422-020-0282-0
  2. Sheahan TP, Sims AC, Leist SR, Schäfer A, Won J, Brown AJ, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020;11(1):222.https://doi.org/10.1038/s41467-019-13940-6
  3. Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. 2020;NEJMoa2007016.https://doi.org/10.1056/NEJMoa2007016
  4. Drazen JM. Data Sharing and the Journal. N Engl J Med. 2016;374(19):e24.https://doi.org/10.1056/NEJMe1601087
  5. Hasan K, et al. COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal. J Heart Lung Transplant. 2020. [Epub ahead of print].
  6. Gottlieb MS. Discovering AIDS. Epidemiology. 1998;9(4):365–7.https://doi.org/10.1097/00001648-199807000-00001
  7. McBride WG. Thalidomide and congenital abnormalities. Lancet. 1961;278(7216):1358. doi:.https://doi.org/10.1016/S0140-6736(61)90927-8
  8. Riou B, Barriot P, Rimailho A, Baud FJ. Treatment of severe chloroquine poisoning. N Engl J Med. 1988;318(1):1–6.https://doi.org/10.1056/NEJM198801073180101
  9. Morris AH, Wallace CJ, Menlove RL, Clemmer TP, Orme JF, Jr, Weaver LK, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med. 1994;149(2 Pt 1):295–305.https://doi.org/10.1164/ajrccm.149.2.8306022